Data published in the Human Protein Atlas (available from http://www.proteinatlas.org) show 3-year survival in 26% of patients with increased SCD expression in a tumor and only in 5% patients with lower SCD expression [65,66]; however, these data are statistically insignificant (p = 0.11). The gene discussed is SCD; the disease is neoplasm.